IRM-COG: Exploration of Neural Bases in Social Cognition

Sponsor
University Hospital, Caen (Other)
Overall Status
Unknown status
CT.gov ID
NCT02110017
Collaborator
(none)
60
1
2
24
2.5

Study Details

Study Description

Brief Summary

An impairment in social cognition in schizophrenia could account for the severe professional and social difficulties among patients. Social cognition is the way the social world is understood, perceived and interpreted. It includes all the process than enable oneself to interact with another person, namely emotion perception and processing, theory of mind (ToM), social perception, social knowledge and attributional style. Since these process are interconnected, social cognition should be investigated through ecological tasks which activate all of them together. Developing a social cognition ecological task, then testing the reproducibility of the functional magnetic resonance imagery (fMRI) BOLD signal is the main objective of this study. The secondary objective is to seek a functional deficit among the neural network of social cognition in patients with schizophrenia compared with healthy subjects.

Forty healthy subjects, aged from 18 to 60 years old, who have given a written consent, will be included. The social cognition paradigm will be developed and the fMRI activations will be compared to those of a visual cartoon based task, known to turn on the neural network of ToM. BOLD signal variations at a high statistical correction ratio (p<0.05) will be explored and compared to the signal of a second fMRI, made on the same 20 healthy subjects one month later, to test reproducibility (% of identical activated voxels during the 2 fMRI, p<0.05).

Twenty matched patients with schizophrenia (DSM-IV-R), aged from 18 to 60 will be included to test the secondary objective. We make the hypothesis of a fMRI functional alteration in the cerebral network involved in social cognition, especially in the medial prefrontal cortex, among patients compared with healthy subjects.

Condition or Disease Intervention/Treatment Phase
  • Other: fMRI social cognition task
N/A

Detailed Description

Social cognition neural basis. Impairment of the "social brain" in schizophrenia

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Exploration of Neural Bases in Social Cognition
Study Start Date :
Sep 1, 2013
Anticipated Primary Completion Date :
Sep 1, 2015
Anticipated Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: Patients with schizophrenia

Twenty patients suffering from schizophrenia (DSM-IV-R), with medication and medical care. No recent relapse of the psychotic disease, nor change in medications. No neurological comorbidity. After anatomic scans, each subject will go through the fMRI social cognition task.

Other: fMRI social cognition task
fMRI social cognition task : each subject will go through 3 runs of a fMRI paradigm, first one verbal then two visual runs, which are meant to activate the theory of mind network.
Other Names:
  • Philips 3 Tesla fMRI
  • Other: Healthy subjects

    Twenty healthy subjects (no mental or neurological disease) After anatomic scans, each subject will go through the fMRI social cognition task.

    Other: fMRI social cognition task
    fMRI social cognition task : each subject will go through 3 runs of a fMRI paradigm, first one verbal then two visual runs, which are meant to activate the theory of mind network.
    Other Names:
  • Philips 3 Tesla fMRI
  • Outcome Measures

    Primary Outcome Measures

    1. Developing a social cognition ecological task, then testing the reproducibility of the functional magnetic resonance imagery (fMRI) BOLD signal [Day 1 for individual analysis. Up to 24 months for group analysis.]

      The social cognition paradigm will be developed and the fMRI activations will be compared to those of a visual cartoon based task, known to turn on the neural network of ToM. BOLD signal variations at a high statistical correction ratio (p<0.05) will be explored and compared to the signal of a second fMRI, made on the same 20 healthy subjects one month later, to test reproducibility (% of identical activated voxels during the 2 fMRI, p<0.05)

    Secondary Outcome Measures

    1. Identifying a functional deficit among the neural network of social cognition in patients with schizophrenia compared with healthy subjects. [Day 1 for individual analysis. Up to 24 months for group analysis.]

      Using the previous social cognition ecological task, BOLD signal variations at a high statistical correction ratio (p<0.05) of 20 patients with schizophrenia will be compared to those of 20 matched healthy subjects.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Subjects aged from 18 to 60 years old

    • who have signed a consent and, if there is one, whose legal representant has signed a consent

    1)For healthy subjects:

    • without any psychiatric affection (Mini International Neuropsychiatric Interview)

    2)For patients

    • meeting the DSM-IV-R criteria for schizophrenia or schizoaffective disorder
    Exclusion Criteria:
    • pregnant woman

    • neurological affection

    • medical objection to Magnetic Resonance Imagery (MRI)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centre Hospitalier Universitaire Caen Normandy France 14000

    Sponsors and Collaborators

    • University Hospital, Caen

    Investigators

    • Principal Investigator: Perrine BRAZO, MD-PhD, University of Caen, UMR 6301 ISTCT ISTS group; CNRS UMR 6301 ISTCT GIP Cyceron; CEA UMR 6301 ISTCT; CHU de Caen, Department of psychiatry, Centre Esquirol

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Caen
    ClinicalTrials.gov Identifier:
    NCT02110017
    Other Study ID Numbers:
    • RCB 2013-A00064-41
    First Posted:
    Apr 10, 2014
    Last Update Posted:
    Feb 5, 2015
    Last Verified:
    Feb 1, 2015
    Keywords provided by University Hospital, Caen
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 5, 2015